WO2000064435A1 - Preparations a base d'oxybutynine destinees a etre absorbees par voie percutanee - Google Patents
Preparations a base d'oxybutynine destinees a etre absorbees par voie percutanee Download PDFInfo
- Publication number
- WO2000064435A1 WO2000064435A1 PCT/JP2000/002697 JP0002697W WO0064435A1 WO 2000064435 A1 WO2000064435 A1 WO 2000064435A1 JP 0002697 W JP0002697 W JP 0002697W WO 0064435 A1 WO0064435 A1 WO 0064435A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- preparation
- oxyptinin
- skin
- solvent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU38430/00A AU3843000A (en) | 1999-04-26 | 2000-04-25 | Percutaneous absorption preparations containing oxybutynin |
EP00917457A EP1174132A4 (en) | 1999-04-26 | 2000-04-25 | PREPARATIONS THAT CONTAIN OXYBUTYNIN FOR PERCUTANEOUS ABSORPTION |
KR1020017013755A KR20020012549A (ko) | 1999-04-26 | 2000-04-25 | 옥시부티닌 함유 경피흡수 제제 |
CA002370592A CA2370592A1 (en) | 1999-04-26 | 2000-04-25 | Percutaneous absorption preparations containing oxybutynin |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP1999/002213 WO2000064434A1 (fr) | 1999-04-26 | 1999-04-26 | Preparations percutanees contenant de l'oxybutynine |
JPPCT/JP99/02213 | 1999-04-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000064435A1 true WO2000064435A1 (fr) | 2000-11-02 |
Family
ID=14235564
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1999/002213 WO2000064434A1 (fr) | 1999-04-26 | 1999-04-26 | Preparations percutanees contenant de l'oxybutynine |
PCT/JP2000/002697 WO2000064435A1 (fr) | 1999-04-26 | 2000-04-25 | Preparations a base d'oxybutynine destinees a etre absorbees par voie percutanee |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1999/002213 WO2000064434A1 (fr) | 1999-04-26 | 1999-04-26 | Preparations percutanees contenant de l'oxybutynine |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1174132A4 (ja) |
KR (1) | KR20020012549A (ja) |
CN (1) | CN1348367A (ja) |
AU (2) | AU3536799A (ja) |
CA (1) | CA2370592A1 (ja) |
WO (2) | WO2000064434A1 (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005255649A (ja) * | 2004-03-15 | 2005-09-22 | Mycoal Products Corp | 貼付シート |
WO2005102306A1 (ja) * | 2004-04-23 | 2005-11-03 | Hisamitsu Pharmaceutical Co., Inc. | 消炎鎮痛貼付剤 |
WO2006082728A1 (ja) * | 2005-02-04 | 2006-08-10 | Hisamitsu Pharmaceutical Co., Inc. | 経皮吸収貼付剤 |
WO2006082888A1 (ja) * | 2005-02-03 | 2006-08-10 | Kyorin Pharmaceutical Co., Ltd. | 経皮吸収型製剤 |
WO2006098353A1 (ja) * | 2005-03-15 | 2006-09-21 | Kyowa Hakko Kogyo Co., Ltd. | 外用剤 |
JP2012219099A (ja) * | 2011-04-08 | 2012-11-12 | Pfizer Inc | 結晶性ピロロ[2,3−d]ピリミジン化合物 |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7179483B2 (en) | 2000-04-26 | 2007-02-20 | Watson Pharmaceuticals, Inc. | Compositions and methods for transdermal oxybutynin therapy |
WO2003092704A1 (fr) * | 2002-04-30 | 2003-11-13 | Mochida Pharmaceutical Co., Ltd. | Preparation externe de vidarabine a propriete systemique amelioree |
US20050266062A1 (en) * | 2002-11-05 | 2005-12-01 | Lead Ch Emical Co., Ltd. | Percutaneous absorption preparation containing 3-methyl-1-phenyl-2-pyrazolin-5-one |
US8076368B2 (en) | 2003-11-12 | 2011-12-13 | Lead Chemical Co., Ltd, | Percutaneous absorption type cerebral protective agent |
EP1731147A4 (en) * | 2004-03-31 | 2010-06-30 | Kowa Co | EXTERNAL PREPARATION |
JP4943643B2 (ja) * | 2004-10-29 | 2012-05-30 | テイカ製薬株式会社 | 経皮吸収製剤 |
CN103919754B (zh) * | 2013-01-15 | 2018-11-06 | 江苏康倍得药业股份有限公司 | 奥昔布宁药物组合物及其应用 |
WO2017145441A1 (ja) * | 2016-02-25 | 2017-08-31 | 久光製薬株式会社 | 外用液剤 |
EP4069210A1 (en) * | 2019-12-02 | 2022-10-12 | Dyve Biosciences, Inc. | Transdermal penetration by modulating epithelial junctions |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0446636A2 (en) * | 1990-03-12 | 1991-09-18 | Showa Denko Kabushiki Kaisha | External application base or auxiliary agent and external application composition for human being or animal containing the same |
JPH04266821A (ja) * | 1991-02-22 | 1992-09-22 | Riide Chem Kk | 経皮吸収型頻尿・尿失禁治療剤 |
JPH09143061A (ja) * | 1995-11-20 | 1997-06-03 | Showa Denko Kk | 鎮痛剤用経皮吸収製剤 |
JPH09176015A (ja) * | 1995-12-28 | 1997-07-08 | Showa Denko Kk | 鎮痛消炎外用貼付剤 |
JPH1025243A (ja) * | 1996-07-09 | 1998-01-27 | Showa Denko Kk | 鎮痛消炎外用貼付剤 |
JPH10316590A (ja) * | 1997-05-14 | 1998-12-02 | Showa Denko Kk | 局所麻酔用外用剤 |
EP0965626A1 (en) * | 1998-06-18 | 1999-12-22 | SSP Co., Ltd. | Hydrophilic adhesive masses |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH062150B2 (ja) * | 1983-09-12 | 1994-01-12 | リ−ドケミカル株式会社 | 貼付剤用基剤 |
JPH082801B2 (ja) * | 1989-11-09 | 1996-01-17 | 株式会社資生堂 | 経皮吸収促進剤及び皮膚外用剤 |
JPH04273818A (ja) * | 1991-02-28 | 1992-09-30 | Kissei Pharmaceut Co Ltd | 経皮投与製剤 |
JPH0776526A (ja) * | 1993-09-06 | 1995-03-20 | Sansei Seiyaku Kk | 乳酸エステルを含有する経皮吸収製剤 |
EP0721348B1 (en) * | 1993-09-29 | 1999-09-01 | Alza Corporation | Monoglyceride/lactate ester permeation enhancer |
WO1995031190A1 (fr) * | 1994-05-18 | 1995-11-23 | Hisamitsu Pharmaceutical Co., Inc. | Preparation administrable par voie percutanee pour le traitement des troubles de la miction |
US5635203A (en) * | 1994-09-29 | 1997-06-03 | Alza Corporation | Transdermal device having decreased delamination |
US5601839A (en) * | 1995-04-26 | 1997-02-11 | Theratech, Inc. | Triacetin as a penetration enhancer for transdermal delivery of a basic drug |
-
1999
- 1999-04-26 WO PCT/JP1999/002213 patent/WO2000064434A1/ja active Application Filing
- 1999-04-26 AU AU35367/99A patent/AU3536799A/en not_active Abandoned
-
2000
- 2000-04-25 WO PCT/JP2000/002697 patent/WO2000064435A1/ja not_active Application Discontinuation
- 2000-04-25 AU AU38430/00A patent/AU3843000A/en not_active Abandoned
- 2000-04-25 CA CA002370592A patent/CA2370592A1/en not_active Abandoned
- 2000-04-25 EP EP00917457A patent/EP1174132A4/en not_active Withdrawn
- 2000-04-25 CN CN00806770A patent/CN1348367A/zh active Pending
- 2000-04-25 KR KR1020017013755A patent/KR20020012549A/ko not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0446636A2 (en) * | 1990-03-12 | 1991-09-18 | Showa Denko Kabushiki Kaisha | External application base or auxiliary agent and external application composition for human being or animal containing the same |
JPH04266821A (ja) * | 1991-02-22 | 1992-09-22 | Riide Chem Kk | 経皮吸収型頻尿・尿失禁治療剤 |
JPH09143061A (ja) * | 1995-11-20 | 1997-06-03 | Showa Denko Kk | 鎮痛剤用経皮吸収製剤 |
JPH09176015A (ja) * | 1995-12-28 | 1997-07-08 | Showa Denko Kk | 鎮痛消炎外用貼付剤 |
JPH1025243A (ja) * | 1996-07-09 | 1998-01-27 | Showa Denko Kk | 鎮痛消炎外用貼付剤 |
JPH10316590A (ja) * | 1997-05-14 | 1998-12-02 | Showa Denko Kk | 局所麻酔用外用剤 |
EP0965626A1 (en) * | 1998-06-18 | 1999-12-22 | SSP Co., Ltd. | Hydrophilic adhesive masses |
Non-Patent Citations (1)
Title |
---|
See also references of EP1174132A4 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005255649A (ja) * | 2004-03-15 | 2005-09-22 | Mycoal Products Corp | 貼付シート |
WO2005102306A1 (ja) * | 2004-04-23 | 2005-11-03 | Hisamitsu Pharmaceutical Co., Inc. | 消炎鎮痛貼付剤 |
WO2006082888A1 (ja) * | 2005-02-03 | 2006-08-10 | Kyorin Pharmaceutical Co., Ltd. | 経皮吸収型製剤 |
JP5020061B2 (ja) * | 2005-02-03 | 2012-09-05 | 杏林製薬株式会社 | 経皮吸収型製剤 |
WO2006082728A1 (ja) * | 2005-02-04 | 2006-08-10 | Hisamitsu Pharmaceutical Co., Inc. | 経皮吸収貼付剤 |
WO2006098353A1 (ja) * | 2005-03-15 | 2006-09-21 | Kyowa Hakko Kogyo Co., Ltd. | 外用剤 |
JP2012219099A (ja) * | 2011-04-08 | 2012-11-12 | Pfizer Inc | 結晶性ピロロ[2,3−d]ピリミジン化合物 |
Also Published As
Publication number | Publication date |
---|---|
CN1348367A (zh) | 2002-05-08 |
EP1174132A4 (en) | 2002-08-07 |
EP1174132A1 (en) | 2002-01-23 |
AU3843000A (en) | 2000-11-10 |
WO2000064434A1 (fr) | 2000-11-02 |
AU3536799A (en) | 2000-11-10 |
CA2370592A1 (en) | 2000-11-02 |
KR20020012549A (ko) | 2002-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7071330B2 (ja) | 炭酸水素ナトリウムのin situ変換で促進されたアミン薬物の経皮送達 | |
US6239177B1 (en) | Tranilast-containing preparation for external application and method of producing the same | |
JP5403948B2 (ja) | メマンチン含有経皮吸収製剤 | |
WO2000064435A1 (fr) | Preparations a base d'oxybutynine destinees a etre absorbees par voie percutanee | |
JP5236760B2 (ja) | 爪用貼付剤 | |
US20130211353A1 (en) | Percutaneous absorption type formulation | |
JP5548329B2 (ja) | 経皮吸収型製剤 | |
JP4764337B2 (ja) | 消炎鎮痛貼付剤 | |
JP7391848B2 (ja) | 外用製剤 | |
WO2000001384A1 (fr) | Preparation a base de ketotifene destinee a etre absorbee par voie percutanee | |
JPH04217919A (ja) | エペリゾンまたはトルペリゾン経皮吸収製剤 | |
JPH10231248A (ja) | ジヒドロエトルフィン含有経皮吸収型製剤 | |
JP5888706B2 (ja) | ロキソプロフェンナトリウム含有外用貼付剤 | |
JPH0753671B2 (ja) | 経皮・経粘膜製剤 | |
JP6459148B2 (ja) | 経皮吸収型製剤 | |
JP2001058961A (ja) | 経皮吸収促進剤及び経皮吸収型製剤 | |
JP4237293B2 (ja) | 経皮吸収型貼付剤 | |
WO2018104772A1 (ja) | 経皮吸収型製剤 | |
JP6512905B2 (ja) | フェンタニル含有貼付剤 | |
WO2017057541A1 (ja) | 経皮吸収型製剤 | |
JP4567998B2 (ja) | 親水性粘着剤を用いた親水性皮膚外用粘着剤組成物および親水性貼付剤 | |
CA2244679C (en) | Tranilast-containing preparation for external application and method of producing the same | |
JPH04202140A (ja) | 経皮吸収製剤 | |
JP2001233764A (ja) | N−置換−o−トルイジン誘導体からなる鎮痒剤 | |
JP2021102573A (ja) | クエン酸フェンタニル含有経皮吸収製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 00806770.8 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2000 613426 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2370592 Country of ref document: CA Ref document number: 2370592 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000917457 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 38430/00 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020017013755 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09958074 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2000917457 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017013755 Country of ref document: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000917457 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1020017013755 Country of ref document: KR |